Abstracts Archive - Page 1184 of 1683 - ATC Abstracts

2016 American Transplant Congress
Low Risk of Cytomegalovirus (CMV) Transmission in Clinical Islet Transplantation.
D. Kabbani,¹ K. Cheung,² P. Senior,² C. Cervera,¹ K. Doucette,¹ J. Preiksaitis.¹
¹Infectious Diseases, University of Alberta, Edmonton, AB, Canada; ²Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada.
Background:In solid organ transplantation (SOT), CMV is commonly transmitted from seropositive organ donors (D+) to seronegative recipients (R-), despite the use of antiviral prophylaxis. The…
2016 American Transplant Congress
MicroRNA-375 and -200c Are a Set of Novel Biomarkers That Can Predict Islet Autotransplantation Outcome.
G. Yoshimatsu,¹ M. Kanak,² M. Takita,¹ S. Prathab Balaji,¹ C. Chang,¹ M. Lawrence,¹ M. Levy,² N. Onaca,³ P. Kim,³ B. Naziruddin.³
¹Islet Cell Laboratory, Baylor Research Institute, Dallas, TX; ²Transplant Division, Department of Surgery, VCU Medical Center, Richmond, VA; ³Baylor Simmons Transplant Institute, Dallas, TX.
Introduction: Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment for refractive chronic pancreatitis to relieve pain and retain endocrine function. Patient selection is…
2016 American Transplant Congress
Validation of SUITO Index and C-Peptide/Glucose Creatinine Ratio as Convenient Tools for the Evaluation of the Short and Long-Term Islet Allograft Function.
J. Gołębiewska,¹ J. Solomina,² S. Matosz,² C. Thomas,³ L. Schenck,² K. Golab,² W. Chon,³ S. Ramachandran,² M. Tibudan,² A. Dębska-ŚLizień,¹ B. Rutkowski,¹ P. Witkowski.²
¹Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland; ²Department of Surgery, University of Chicago, Chicago, IL; ³Department of Medicine, University of Chicago, Chicago, IL.
Background: Mixed Meal Tolerance Test (MMTT) together with the beta-score are standard tools to evaluate beta-cell function after islet transplantation but utilization of the test…
2016 American Transplant Congress
Total Pancreatectomy with Islet Autotransplantation for Chronic Pancreatitis: Considerations for Early Intervention.
J. Jolissaint,¹ L. Langman,¹ C. DeBolt,¹ A. Wang,² D. Strand,² V. Zaydfudim,¹ R. Adams,¹ K. Brayman.¹
¹Department of Surgery, University of Virginia, Charlottesville, VA; ²Department of Medicine, University of Virginia, Charlottesville, VA.
Introduction: Total pancreatectomy with islet autotransplantation (TPIAT) provides pain relief for patients with chronic pancreatitis (CP) and the potential to ameliorate the resulting endocrine insufficiency.…
2016 American Transplant Congress
Isolating High Islet Mass Even from Alcoholic Pancreatitis Pancreases Intended for Clinical Islet Auto-Transplantation: Improved Strategies to Human Islet Isolation Technique.
A. Balamurugan, G. Loganathan, B. Tweed, W. Tucker, S. Mokshagundam, S. Williams, M. Hughes.
Surgery, Clinical Islet Cell Laboratory, Cardiovascular Innovation Insitute, Louisville, KY.
It has been reported in the literature that after pancreatic resection with planned islet auto-transplantation (IAT), islets isolated from alcoholic pancreatitis (AP) pancreases resulted in…
2016 American Transplant Congress
Risk Factors for Early Readmission After Total Pancreatectomy with Islet Auto Transplantation.
R. Shahbazov,¹ N. Bashoo,² G. Yoshimatsu,² G. Saracino,² F. Azari,¹ N. Onaca,² P. Kim,² M. Levy.³
¹Charles O.Strikler Transplant Center, Department of Surgery, University of Virginia, Charlottesville, VA; ²Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX; ³Transplant Division, Virginia Commonwealth University, Richmond, VA.
Introduction: Readmission after Total Pancreatectomy with Islet Auto Transplantation (TPIAT) is common, but no data is available on reasons for readmission and islet graft function.Aims:…
2016 American Transplant Congress
Comparison of Outcomes from Patients with Completion versus Total Pancreatectomy with Islet Autotransplantation: A Single-Institution Experience with 120 Consecutive Cases.
G. Yoshimatsu,¹ M. Takita,¹ R. Shahbazov,² M. Lawrence,¹ B. Naziruddin,³ P. Kim,³ M. Levy,⁴ N. Onaca.³
¹Islet Cell Laboratory, Baylor Research Institute, Dallas, TX; ²Department of Surgery, University of Virginia, Charlottesville, VA; ³Transplant Division, VCU Medical Center, Richmond, VA; ⁴Baylor Simmons Transplant Institute, Dallas, TX.
Introduction: Total pancreatectomy (TP) or completion pancreatectomy is considered to effectively eliminate the severe pain from refractory chronic pancreatitis, if prior procedures failed. Islet autotransplantation…
2016 American Transplant Congress
Effect of Pylorus Preservation Procedure on Patient and Graft Outcome in Total Pancreatectomy with Islet Autotransplantation.
R. Shahbazov,¹ A. Dabous,² G. Yoshimatsu,² H. Fernandez,² G. Saracino,² B. Naziruddin,² N. Onaca,² P. Kim,² M. Levy.³
¹Department of Surgery, University of Virginia, Charlottsville, VA; ²Baylor Simmons Transplant Institute, Dallas, TX; ³Transplant Division, VCU Medical Center, Richmond, VA.
Introduction: Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment to retain pancreatic endocrine function while alleviating intractable pain in Chronic Pancreatitis. The role…
2016 American Transplant Congress
Periodical Peer Review of a Pancreas Transplant Programme: Can It Enhance Performance?
Z. Moinuddin, A. Arif, O. Masood, A. Tavakoli, R. Pararajsingam, K. Poulton, J. Worthington, B. Forgacs, T. Augustine, R. Dhanda.
Department of Renal and Pancreas Transplantation, Manchester Royal Infirmary, Manchester, Lancashire, United Kingdom.
Introduction:In the UK, NHS Blood and Transplant (NHSBT), the national transplant regulatory body, monitors 30-day graft loss and patient mortality by CUmulative SUMmation methodology (CUSUM).…
2016 American Transplant Congress
Outcomes of Solid Organ Transplants Following Simultaneous Solid Organ and Vascularized Composite Allograft Procurements.
M. Alhefzi,¹ M. Aycart,¹ G. Sharma,² N. Krezdorn,¹ E. Bueno,¹ S. Talbot,¹ M. Carty,¹ B. Pomahac,¹ S. Tullius.³
¹Department of Surgery, Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; ²Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; ³Department of Surgery, Division of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Background: Current knowledge of the impact of facial vascularized composite allograft (VCA) procurement on the transplantation outcomes of the concomitantly recovered life-saving organs is limited…